News - Page 215 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Champignon Brands’ Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression

Champignon Brands’ Canadian Rapid Treatment Center of Excellence Opens First Community-Based Centre in Ottawa to Provide Ketamine Treatment for Adults With Depression

Post published:January 25, 2021
Post category:Press Release

Read more about the article Psyched Wellness Upsizes Previously Announced Bought Deal Offering

Psyched Wellness Upsizes Previously Announced Bought Deal Offering

Post published:January 25, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: Psychedelics Index Published; ETF Launching Jan 27; MindMed Commences Candyflipping Trial

Psychedelic Bulletin: Psychedelics Index Published; ETF Launching Jan 27; MindMed Commences Candyflipping Trial

Post published:January 22, 2021
Post category:Psychedelic Bulletin

Read more about the article Mind Cure Health Inc. Announces an Increase to Previously Announced Bought Deal Public Offering

Mind Cure Health Inc. Announces an Increase to Previously Announced Bought Deal Public Offering

Post published:January 22, 2021
Post category:Press Release

Read more about the article Horizons ETFs to Launch World’s First Psychedelics-Focused ETF

Horizons ETFs to Launch World’s First Psychedelics-Focused ETF

Post published:January 22, 2021
Post category:Press Release

Read more about the article Numinus Announces Listing of Warrants

Numinus Announces Listing of Warrants

Post published:January 22, 2021
Post category:Press Release

Read more about the article Mind Cure Health Inc. Announces $10 Million Bought Deal Public Offering

Mind Cure Health Inc. Announces $10 Million Bought Deal Public Offering

Post published:January 21, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Files Preliminary Prospectus in Connection with Bought Deal Offering of Units

Mydecine Innovations Group Files Preliminary Prospectus in Connection with Bought Deal Offering of Units

Post published:January 21, 2021
Post category:Press Release

Read more about the article North American Psychedelics Index Published: Which Companies Will Be in the First Psychedelic ETF?

North American Psychedelics Index Published: Which Companies Will Be in the First Psychedelic ETF?

Post published:January 21, 2021
Post category:Analysis News

Read more about the article Psyched Wellness Announces C$3M Bought Deal Private Placement Led by Canaccord Genuity

Psyched Wellness Announces C$3M Bought Deal Private Placement Led by Canaccord Genuity

Post published:January 21, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.